Fidelity Investments’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.7M | Sell |
54,197
-106,388
| -66% | -$49.1M | ﹤0.01% | 1738 |
|
|
2026
Q1 | $77.1M | Sell |
160,585
-43,136
| -21% | -$22.1M | ﹤0.01% | 1275 |
|
|
2025
Q4 | $114M | Buy |
203,721
+195,907
| +2,507% | +$111M | 0.01% | 1115 |
|
|
2025
Q3 | $4.02M | Sell |
7,814
-19,133
| -71% | -$8.35M | ﹤0.01% | 2313 |
|
|
2025
Q2 | $8.46M | Sell |
26,947
-21,323
| -44% | -$6.4M | ﹤0.01% | 1996 |
|
|
2025
Q1 | $14.7M | Sell |
48,270
-63,953
| -57% | -$21.5M | ﹤0.01% | 1785 |
|
|
2024
Q4 | $37.3M | Sell |
112,223
-118,796
| -51% | -$40.3M | ﹤0.01% | 1499 |
|
|
2024
Q3 | $77.1M | Buy |
231,019
+24,362
| +12% | +$9.25M | ﹤0.01% | 1203 |
|
|
2024
Q2 | $85.1M | Sell |
206,657
-26,176
| -11% | -$10.4M | 0.01% | 1107 |
|
|
2024
Q1 | $94.1M | Sell |
232,833
-7,947
| -3% | -$2.79M | 0.01% | 1080 |
|
|
2023
Q4 | $73.8M | Buy |
240,780
+1,171
| +0.5% | +$316K | 0.01% | 1132 |
|
|
2023
Q3 | $58M | Sell |
239,609
-3,618
| -1% | -$925K | 0.01% | 1197 |
|
|
2023
Q2 | $58.4M | Buy |
243,227
+154,317
| +174% | +$32.1M | ﹤0.01% | 1217 |
|
|
2023
Q1 | $16.7M | Buy |
88,910
+57,596
| +184% | +$11.9M | ﹤0.01% | 1687 |
|
|
2022
Q4 | $6.65M | Sell |
31,314
-152,151
| -83% | -$30.4M | ﹤0.01% | 2035 |
|
|
2022
Q3 | $28.8M | Sell |
183,465
-26,849
| -13% | -$4.28M | ﹤0.01% | 1480 |
|
|
2022
Q2 | $31.5M | Sell |
210,314
-118,271
| -36% | -$17.1M | ﹤0.01% | 1466 |
|
|
2022
Q1 | $53.8M | Buy |
328,585
+21,449
| +7% | +$3.54M | ﹤0.01% | 1361 |
|
|
2021
Q4 | $66.8M | Buy |
307,136
+18,138
| +6% | +$3.8M | ﹤0.01% | 1298 |
|
|
2021
Q3 | $54.7M | Buy |
288,998
+14,457
| +5% | +$2.64M | ﹤0.01% | 1374 |
|
|
2021
Q2 | $48.5M | Sell |
274,541
-118,104
| -30% | -$20.4M | ﹤0.01% | 1446 |
|
|
2021
Q1 | $64.4M | Buy |
392,645
+130,308
| +50% | +$19.9M | 0.01% | 1274 |
|
|
2020
Q4 | $36.5M | Buy |
262,337
+224,785
| +599% | +$28.3M | ﹤0.01% | 1455 |
|
|
2020
Q3 | $4.2M | Buy |
37,552
+37,107
| +8,339% | +$4.29M | ﹤0.01% | 2121 |
|
|
2020
Q2 | $41K | Sell |
445
-201
| -31% | -$17.1K | ﹤0.01% | 2841 |
|
|
2020
Q1 | $47K | Buy |
646
+186
| +40% | +$16.1K | ﹤0.01% | 2782 |
|
|
2019
Q4 | $39K | Sell |
460
-32
| -7% | -$2.48K | ﹤0.01% | 2955 |
|
|
2019
Q3 | $41K | Buy |
492
+36
| +8% | +$2.72K | ﹤0.01% | 2906 |
|
|
2019
Q2 | $30K | Sell |
456
-36,791
| -99% | -$2.12M | ﹤0.01% | 2975 |
|
|
2019
Q1 | $2.2M | Buy |
37,247
+36,700
| +6,709% | +$2.19M | ﹤0.01% | 2272 |
|
|
2018
Q4 | $29K | Buy |
547
+68
| +14% | +$3.73K | ﹤0.01% | 2831 |
|
|
2018
Q3 | $29K | Buy |
+479
| New | +$26.2K | ﹤0.01% | 2926 |
|
|
2017
Q2 | – | Sell |
-449,768
| Closed | -$13.4M | – | 2651 |
|
|
2017
Q1 | $13.4M | Sell |
449,768
-488,669
| -52% | -$15.8M | ﹤0.01% | 1849 |
|
|
2016
Q4 | $33.8M | Sell |
938,437
-83,500
| -8% | -$2.78M | ﹤0.01% | 1470 |
|
|
2016
Q3 | $30.5M | Buy |
+1,021,937
| New | +$29.8M | ﹤0.01% | 1496 |
|
Other funds holding MEDP
WA
Fidelity Investments's MEDP Position: Q2 2026 in Review
Fidelity Investments reduced its Medpace (MEDP) stake by 66% in Q2 2026, selling an estimated $49.1M and leaving 54,197 shares worth $28.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1738.
Fidelity Investments first reported a position in MEDP in Q3 2016 and has held it in 35 quarters since. The position peaked at $114M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Fidelity Investments held 54,197 shares of Medpace worth $28.7M as of Q2 2026.
- Fidelity Investments sold 106,388 Medpace shares in Q2 2026, an estimated $49.1M.
- Medpace made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1738 holding.
- Fidelity Investments first reported a position in Medpace in Q3 2016 and has held it in 35 quarters since.
- Fidelity Investments's Medpace position peaked at $114M in Q4 2025.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.